Category: takeout
-
Maravai LifeSciences may be worth $15 to $20 share in a takeout – analyst
•
franckreporter/E+ via Getty Images Maravai Life Sciences (NASDAQ: MROV) could be worth $15 to $20 per share in a potential acquisition based on previous transactions, according to an RBC analyst, after a report that Repligen (RGEN) has made an offer for the vaccine reagent vendor. Maravai Stock (MRVI)) jump 23%…